16
Participants
Start Date
January 18, 2022
Primary Completion Date
March 17, 2023
Study Completion Date
March 17, 2023
ABBV-951
Continuous Subcutaneous Infusion (CSCI)
Georgetown University Hospital /ID# 230224, Washington D.C.
Rush University Medical Center /ID# 229983, Chicago
Parkinson Disease Movement Disorders Clinic /ID# 245791, Austin
University of Colorado Hospital /ID# 229974, Aurora
University of Utah Health Care /ID# 241219, Salt Lake City
Carolina Phase 1, LLC /ID# 239836, Raleigh
The Movement Disorder Clinic of Oklahoma /ID# 238610, Tulsa
Vanderbilt University Medical Center /ID# 230255, Nashville
Texas Movement Disorder Specialists /ID# 238607, Georgetown
Baylor College of Medicine - Baylor Medical Center /ID# 239631, Houston
Lead Sponsor
AbbVie
INDUSTRY